MedTrace Logo

Velocity Vector Imaging in Patients With Moderate-to-Severe Aortic Regurgitation

NCT00624884 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2008-06-30

No results posted yet for this study

Summary

Velocity Vector Imaging may provide reliable and detailed information on left ventricular segmental function in asymptomatic patients with moderate-to severe AR. This may help to identify subclinical myocardial dysfunction in order to operate early enough to prevent postoperative heart failure and restrict unnecessary early operation which could be associated with operative risks and mortality related to prosthetic valves.

Conditions

  • Aortic Regurgitation

Sponsors & Collaborators

  • Florence Nightingale Hospital, Istanbul

    lead OTHER

Principal Investigators

  • Saide Aytekin, Professor · T.C. Istanbul Bilim University, Florence Nightingale Hospital, Division of Cardiology

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2008-04-30
Completion
2008-05-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00624884 on ClinicalTrials.gov